Skip to main content
. 2018 Jul 16;8:10715. doi: 10.1038/s41598-018-29017-1

Table 2.

One-year changes in SCN parameters, in CIS patients and HCs.

CIS patients (all) HCs Patients vs. HCs, estimated p-value
1. Measures of nodal connectivity
Mean nodal strength, estimated value (bootstrap-based 95% CI), p-value
Change from baseline to 1 year −3.62 (−12.29 to 2.19), p = 0.3 −0.58 (−3.37 to 2.03), p = 0.7 0.50
Mean clustering coefficient, estimated value (bootstrap-based 95% CI), p-value
Change from baseline to 1 year −0.06 (−0.19 to 0.02), p = 0.15 −0.01 (−0.05 to 0.04), p = 0.8 0.30
2. Measures of nodal distance
Mean shortest path, estimated value (bootstrap-based 95% CI), p-value
Change from baseline to 1 year 0.36 (−0.13 to 0.89), p = 0.2 0.03 (−0.06 to 0.13), p = 0.6 0.25
Global efficiency, estimated value (bootstrap-based 95% CI), p-value
Change from baseline to 1 year −0.05 (−0.14 to 0.02), p = 0.15 −1.46 * 10−4 (−0.03 to 0.03), p = 0.99 0.20
Mean local efficiency, estimated value (bootstrap-based 95% CI), p-value
Change from baseline to 1 year −0.06 (−0.17 to 0.01), p = 0.15 −0.005 (−0.05 to 0.04), p = 0.9 0.25
3. Measures of network organisation
Modularity coefficient (bootstrap-based 95% CI), p-value
Change from baseline to 1 year 0.02 (−0.01 to 0.06), p = 0.2 0.0054 (−0.03 to 0.04), p = 0.7 0.60

Comparison between CIS patients and HCs was made looking at the 95% CI. See main text for full details on the methods used. Significant p-values are indicated with bold letters. Abbreviations: CI: confidence interval; CIS: clinically isolated syndrome; FU: follow-up; HCs: healthy controls.